Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Richman

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Blood|March 1, 1977
Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cellsR S Weiner, C M Richman, R A Yankee
Blood|June 1, 1976
Increase in circulating stem cells following chemotherapy in manC M Richman, R S Weiner, R A Yankee
Blood|October 1, 1985
Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximideC A Slapak, R L Fine, C M Richman
Blood|August 1, 1980
Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosomeD G Roth, C M Richman, J D Rowley
Journal of the National Cancer Institute|March 18, 1992
Enhancement of clinical radioimmunotherapy for cancer and the role of cytokinesS J DeNardo, G L DeNardo, C M Richman
Experimental Hematology|January 1, 1979
Dilution techniques for optimum recovery of cryopreserved bone marrow cellsR S Weiner, C M Richman, R A Yankee
The Journal of Clinical Investigation|August 1, 1980
Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiencyK C Rich, C M Richman, E Mejias, et al.
Experimental Hematology|January 1, 1979
Clinical results of autotransplantation after nitrosourea therapyR S Weiner, C M Richman, R A Yankee, et al.
Oncology|January 1, 1986
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinomaC M Richman, E Podczaski, P A Weiser, et al.
Blood|April 1, 1983
Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236BP C Hoffman, C M Richman, R A Larson, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Blood|March 1, 1977
Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cellsR S Weiner, C M Richman, R A Yankee
Blood|June 1, 1976
Increase in circulating stem cells following chemotherapy in manC M Richman, R S Weiner, R A Yankee
Blood|October 1, 1985
Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximideC A Slapak, R L Fine, C M Richman
Blood|August 1, 1980
Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosomeD G Roth, C M Richman, J D Rowley
Journal of the National Cancer Institute|March 18, 1992
Enhancement of clinical radioimmunotherapy for cancer and the role of cytokinesS J DeNardo, G L DeNardo, C M Richman
Experimental Hematology|January 1, 1979
Dilution techniques for optimum recovery of cryopreserved bone marrow cellsR S Weiner, C M Richman, R A Yankee
The Journal of Clinical Investigation|August 1, 1980
Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiencyK C Rich, C M Richman, E Mejias, et al.
Experimental Hematology|January 1, 1979
Clinical results of autotransplantation after nitrosourea therapyR S Weiner, C M Richman, R A Yankee, et al.
Oncology|January 1, 1986
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinomaC M Richman, E Podczaski, P A Weiser, et al.
Blood|April 1, 1983
Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236BP C Hoffman, C M Richman, R A Larson, et al.
Pageof 5